Join
Live feed
·
INSIDERFilingvia Quantisnow
Pardes Biosciences Inc. logo

SEC Form 4: Tananbaum James B. returned 16,813,146 shares to the company and acquired 1,000 shares

ByQuantisnow·Wall Street's wire, on your screen.
PRDS· Pardes Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRDS (Pardes Biosciences Inc.) and more on Quantisnow.